Trial NCT00983580

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

This phase II trial is studying how well giving acetylsalicylic acid together with eflornithine works in treating patients at high risk for colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acetylsalicylic acid and eflornithine may prevent colorectal cancer.

Intervention

Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention

Condition

Adenomatous Polyp

Investigators

See list of participating sites